Recently published results of a phase 2 clinical trial have shown the best outcomes to date for newly diagnosed older Hodgkin lymphoma patients treated with brentuxim...

A new brain imaging clinical trial funded by the National Institutes of Health (NIH) has showed that multiple sclerosis drug ibudilast was better than a placebo at sl...

Pfizer Inc. (NYSE:PFE) and Astellas Pharma Inc. (TSE:4503, President and CEO: Kenji Yasukawa, Ph.D., "Astellas") announced amendments to the protocols for two registr...

Sunday, September 2, 2018: A promising drug slowed brain shrinkage in progressive multiple sclerosis (MS) by nearly half, according to new research led by Cleveland C...

Plymouth Meeting, PA – August 30, 2018: CRF Health, the leading provider of patient-centered eSource technology solutions for the life sciences industry, today announ...